Ranking Profile - Ampio Pharmaceuticals Inc

Introduction

Ampio Pharmaceuticals Inc (Ampio) operates as a biopharmaceutical company. The company discovers and develops novel therapeutic candidates for inflammatory conditions. It provides treatments for inflammatory conditions including osteoarthritis of the knee and osteoarthritis related to other joints such as the hip, shoulder, ankle and hand. The company also offers intra-articular injection treatment for severe OAK, intravenous and inhaled treatment for hospitalized severe COVID-19 patients and inhalation treatment for patients. It operates a manufacturing facility in the US. Ampio is headquartered in Englewood, Colorado, the US.

Company info

Country (HQ): United States
Sector: Pharmaceuticals and Healthcare
Market Cap (US$ m): 4
Revenue (US$ m):

Innovation ranking

271

Innovation score

Closest peers in the Pharmaceuticals and Healthcare sector

Innovation Ranking

Company
Headquarters
Sector

Johnson & Johnson

United States

Pharmaceuticals and Healthcare

F. Hoffmann-La Roche Ltd

Switzerland

Pharmaceuticals and Healthcare

Ampio Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

EyeGate Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

Shin Poong Pharm Co Ltd

South Korea

Pharmaceuticals and Healthcare

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers